LifeCyte Innovations, Inc., 2026-08-20
A new SEC Form D private-offering notice from Greensboro, GA, a $5,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing therapies targeting chronic inflammation in age-related conditions, including an oral combination therapy for age-related macular degeneration.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Monteforte Group, LLC, 2026-09-09, $1.5M, Canton, GA
- Citrachem Corp., 2026-08-21, $500K, Norwood, MA
- Airway Therapeutics, Inc., 2026-09-09, $50.6M, Marietta, GA
- Outer Biosciences Inc, 2026-08-21, $23.3M, Malden, MA
- ASW Holdings, LLC, 2026-09-04, $7.2M, Atlanta, GA
- NurExone Biologic Inc., 2026-08-21, $450K, Technion City, Haifa
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.